1. Active Vitamin D3 Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic Rats. Issue 3 (10th December 2020) Authors: Lee, Pei‐Chang; Hsieh, Yun‐Chen; Huo, Teh‐Ia; Yang, Ueng‐Cheng; Lin, Chao‐Hsiung; Li, Chung‐Pin; Huang, Yi‐Hsiang; Hou, Ming‐Chih; Lin, Han‐Chieh; Lee, Kuei‐Chuan Journal: Molecular nutrition & food research Issue: Volume 65:Issue 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ALBI Grade Determines Post‐progression Survivals after Sorafenib Treatment Failure in Advanced HCC Patients: A Model for Second‐Line Trial Selection: 790. (October 2016) Authors: Lin, Han‐Chieh; Lee, Pei‐Chang; Huang, Yi‐Hsiang; Su, Chien‐Wei; Hou, Ming‐Chih Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti‐VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH‐cirrhotic rat. (2nd September 2013) Authors: Yang, Ying‐Ying; Liu, Ren‐Shyan; Lee, Pei‐Chang; Yeh, Yi‐Chen; Huang, Yi‐Tsau; Lee, Wei‐Ping; Lee, Kuei‐Chuan; Hsieh, Yun‐Cheng; Lee, Fa‐Yauh; Tan, Tat‐Wei; Lin, Han‐Chieh Journal: Liver international Issue: Volume 34:Number 4(2014:May) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats. Issue 5 (May 2014) Authors: Lin, Han‐Chieh; Huang, Yi‐Tsau; Yang, Ying‐Ying; Lee, Pei‐Chang; Hwang, Lih‐Hwa; Lee, Wei‐Ping; Kuo, Ying‐Ju; Lee, Kuei‐Chuan; Hsieh, Yun‐Cheng; Liu, Ren‐Shyan Journal: Journal of gastroenterology and hepatology Issue: Volume 29:Issue 5(2014:May) Page Start: 1073 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparative portal hypotensive effects as propranolol of vitamin D3 treatment by decreasing intrahepatic resistance in cirrhotic rats. Issue 3 (March 2015) Authors: Lee, Pei‐Chang; Yang, Ying‐Ying; Lee, Wei‐Ping; Lee, Kuei‐Chuan; Hsieh, Yun‐Cheng; Lee, Tzung‐Yan; Lin, Han‐Chieh Journal: Journal of gastroenterology and hepatology Issue: Volume 30:Issue 3(2015:Mar.) Page Start: 628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Concomitant inhibition of oxidative stress and angiogenesis by chronic hydrogen‐rich saline and N‐acetylcysteine treatments improves systemic, splanchnic and hepatic hemodynamics of cirrhotic rats. Issue 5 (6th August 2014) Authors: Lee, Pei‐Chang; Yang, Ying‐Ying; Huang, Chien‐Sheng; Hsieh, Shie‐Liang; Lee, Kuei‐Chuan; Hsieh, Yun‐Cheng; Lee, Tzung‐Yan; Lin, Han‐Chieh Journal: Hepatology research Issue: Volume 45:Issue 5(2015:May) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia–reperfusion injury. Issue 7 (July 2017) Authors: Li, Tzu‐Hao; Liu, Chih‐Wei; Lee, Pei‐Chang; Huang, Chia‐Chang; Lee, Kuei‐Chuan; Hsieh, Yun‐Cheng; Yang, Ying‐Ying; Hsieh, Shie‐Liang; Lin, Han‐Chieh; Tsai, Chang‐Youh Journal: Journal of the Chinese Medical Association Issue: Volume 80:Issue 7(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma. (2nd September 2022) Authors: Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A. M.; Nishida, Naoshi; Schönlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U.; Weinmann, Arndt; Galle, Peter R.; Bettinger,... Journal: Liver international Issue: Volume 42:Number 11(2022) Page Start: 2538 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mechanisms of the prevention and inhibition of the progression and development of non‐alcoholic steatohepatitis by genetic and pharmacological decoy receptor 3 supplementation. Issue 12 (24th March 2017) Authors: Lee, Pei‐Chang; Yang, Ling‐Yu; Wang, Ying‐Wen; Huang, Shiang‐Fen; Lee, Kuei‐Chuan; Hsieh, Yun‐Cheng; Yang, Ying‐Ying; Hsieh, Shie‐Liang; Hou, Ming‐Chih; Lin, Han‐Chieh; Lee, Fa‐Yuah; Lee, Shou‐Dong Journal: Hepatology research Issue: Volume 47:Issue 12(2017) Page Start: 1260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC. Issue 7 (28th April 2022) Authors: Sharma, Rohini; Pillai, Anjana; Marron, Thomas Urban; Fessas, Petros; Saeed, Anwaar; Jun, Tomi; Dharmapuri, Sirish; Szafron, David; Naqash, Abdul Rafeh; Gampa, Anuhya; Wang, Yinghong; Khan, Uqba; Muzaffar, Mahvish; Lee, Chieh‐Ju; Lee, Pei‐Chang; Bulumulle, Anushi; Paul, Sonal; Bettinger, Dom... Journal: Hepatology communications Issue: Volume 6:Issue 7(2022) Page Start: 1776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗